Hemanext:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Hemanext - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10530
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hemanext, formerly New Health Sciences Inc, is a medical technology company that develops blood storage systems. The company offers an anaerobic storage system that minimizes oxidative damage to red blood cells in storage and delivers physiologic, therapeutic, and fresher red blood cell than conventional storage systems. It develops a storage system for red blood cells and whole blood, which is designed to preserve their value and safety characteristics during storage, and extends potential storage life. Hemanext offers microvascular analyzer, which is a new test and measurement system that provides both researchers and clinicians a measure of RBC deformability in a simulated capillary network using very small samples. The company collaborates with research organizations to conduct research activities. It caters to blood centers, patients, hospitals and researchers. Hemanext is headquartered in Lexington, Maryland, the US.

Hemanext – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hemanext, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hemanext, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hemanext, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hemanext, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hemanext, Medical Devices Deals, 2012 to YTD 2018 9
Hemanext, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hemanext, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Hemanext Raises USD2 Million in Venture Financing 11
New Health Sciences Raises USD2 Million in Venture Financing 12
Hemanext Raises USD2.7 Million in Venture Financing 13
Hemanext – Key Competitors 14
Hemanext – Key Employees 15
Hemanext – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Strategy And Business Planning 17
Oct 04, 2017: New Health Sciences Announces Company Name Change to Hemanext 17
Product News 18
Mar 06, 2017: Wide Distribution of Initial Oxygen Saturation Levels in Red Cells Stored for Transfusion, May Significantly Influence Cell Quality and Therapeutic Efficacy 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Hemanext, Pharmaceuticals & Healthcare, Key Facts 2
Hemanext, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hemanext, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hemanext, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hemanext, Deals By Therapy Area, 2012 to YTD 2018 8
Hemanext, Medical Devices Deals, 2012 to YTD 2018 9
Hemanext, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hemanext Raises USD2 Million in Venture Financing 11
New Health Sciences Raises USD2 Million in Venture Financing 12
Hemanext Raises USD2.7 Million in Venture Financing 13
Hemanext, Key Competitors 14
Hemanext, Key Employees 15
Hemanext, Subsidiaries 16

List of Figures
Hemanext, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hemanext, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hemanext, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Hemanext, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hemanext, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hemanext, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Hemanext, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hemanext, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hemanext, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Hemanext:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sumitomo Heavy Industries Ltd (6302):電力:M&Aディール及び事業提携情報
    Summary Sumitomo Heavy Industries Ltd (Sumitomo) is a manufacturer of industrial machinery. The company offers a range of products, which include pumps, steam turbines, energy plants, iron and steel manufacturing machinery, cryogenics, environmental systems. It also provides water treatment plants, …
  • Qlik Technologies Inc:企業のM&A・事業提携・投資動向
    Qlik Technologies Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Qlik Technologies Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • The Council of Europe Development Bank:企業の戦略・SWOT・財務情報
    The Council of Europe Development Bank - Strategy, SWOT and Corporate Finance Report Summary The Council of Europe Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Tong Ren Tang Technologies Co Ltd (1666):企業の財務・戦略的SWOT分析
    Summary Tong Ren Tang Technologies Co Ltd (TRTT), a subsidiary of Beijing Tong Ren Tang Co Ltd is a pharmaceutical company that manufactures and supplies Chinese medicines. The company’s products comprise Chinese medicine, healthy food and maier hai cosmetics. It offers products in the forms of pill …
  • Sheetz, Inc.:企業の戦略・SWOT・財務分析
    Sheetz, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sheetz, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • 3i Infotech Ltd (3IINFOTECH):企業の財務・戦略的SWOT分析
    3i Infotech Ltd (3IINFOTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Total SA (FP):企業の財務・戦略的SWOT分析
    Total SA (FP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • FBN Bank (UK) Ltd:企業の戦略・SWOT・財務情報
    FBN Bank (UK) Ltd - Strategy, SWOT and Corporate Finance Report Summary FBN Bank (UK) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • XuanZhu Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary XuanZhu Pharma Co Ltd (XuanZhu), a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd, is a developer and manufacturer of medicinal products. The company’s products comprise anti-infective drugs apapenem and benapenem; anti-acid drug anaprazole sodium, anti-diabetic drug imigliptin hydro …
  • Southern California Edison Co-エネルギー分野:企業M&A・提携分析
    Summary Southern California Edison Company (SCE), a subsidiary of Edison International, is an electric utility that generates, procures, sources, and supplies electricity. The company generates electricity from various sources including natural gas, hydro, nuclear, solar, and oil and gas. It sources …
  • BYD Co Ltd (1211):電力:M&Aディール及び事業提携情報
    Summary BYD Co Ltd (BYD) designs, manufactures and sells rechargeable batteries, photovoltaic products, handset components, and other electronic products. It also offers whole product assembly services. The company manufactures and offers traditional fuel-engine vehicles and new energy vehicles. The …
  • Premier Marketing Public Company Limited:企業の戦略・SWOT・財務情報
    Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Tecnicas Reunidas SA (TRE):企業の財務・戦略的SWOT分析
    Tecnicas Reunidas SA (TRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Rajesh Exports Limited
    Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report Summary Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • The Boeing Company:企業の戦略・SWOT・財務情報
    The Boeing Company - Strategy, SWOT and Corporate Finance Report Summary The Boeing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Juhl Energy Inc:企業の戦略的SWOT分析
    Juhl Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Aduro BioTech Inc (ADRO):製薬・医療:M&Aディール及び事業提携情報
    Summary Aduro BioTech Inc (Aduro BioTech) is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using proprietary technology platforms such as live, attenuated, double-deleted listeria, sti …
  • Bionik Laboratories Corp (BNKL):企業の製品パイプライン分析2018
    Summary Bionik Laboratories Corp (Bionik) is a medical device company that designs and develops transformational technologies, prosthetics and assisted robotic products and solutions. The company provides rehabilitation technology that senses patient movements and limitations. It provides lower body …
  • Green’s General Foods Pty Ltd:企業の戦略・SWOT・財務分析
    Green’s General Foods Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Green’s General Foods Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • RegeneRx Biopharmaceuticals Inc (RGRX):企業の財務・戦略的SWOT分析
    Summary RegeneRx Biopharmaceuticals Inc (RegeneRx) is a clinical-stage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The company offers clinical trials, science and discovery and business development services. Its busine …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆